Research on Alzheimer’s disease has shown TNFSF10’s association with inflammatory responses and cognitive decline, with neutralization of TNFSF10 significantly restoring cognitive behavior and reducing inflammatory mediators in tissues [33]. This evidence concerns the gene TNFSF10 and early-onset autosomal dominant Alzheimer disease.